This inventor holds 2 USPTO granted patents. Top assignee: Cordis Corporation. Active years: 2003-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2004
Title: Michael Dennis O'Hara: Innovator in Radioactive Seed Technology
Introduction
Michael Dennis O'Hara is a notable inventor based in Stewartsville, NJ (US). He has made significant contributions to the field of radiotherapy through his innovative patents. With a total of 2 patents, O'Hara's work focuses on enhancing the efficacy of radioactive seeds used in medical treatments.
Latest Patents
One of O'Hara's latest patents is for a low attenuating radioactive seed. This invention utilizes a core with a fluted or non-circular cross section to increase the dose rate, decrease dwell times, and improve clinical outcomes. The design aims to enhance the therapeutic efficacy of the seed by increasing the surface area for the deposition of the radioactive substance. Additionally, the unique core design reduces photon emission attenuation, allowing for more effective treatment.
Another significant patent by O'Hara is a method and assembly for containing radioactive materials. This invention incorporates a radioactive substance absorber into an intravascular radiotherapy source ribbon assembly. The absorber, made of carbon in various forms, prevents the migration of radioactive matter throughout the assembly container. By positioning the absorber near the source core, it effectively contains any radioactive materials that may break free.
Career Highlights
O'Hara is currently associated with Cordis Corporation, where he continues to develop innovative solutions in the field of radiotherapy. His work has contributed to advancements in medical technology, particularly in improving patient outcomes through enhanced treatment methods.
Collaborations
Throughout his career, O'Hara has collaborated with notable colleagues, including Benjamin David McDaniel and Timothy Charles Kiorpes. These collaborations have fostered a creative environment that encourages innovation and the development of groundbreaking technologies.
Conclusion
Michael Dennis O'Hara's contributions to the field of radiotherapy through his patents demonstrate his commitment to improving medical treatments. His innovative designs and methods have the potential to significantly enhance patient care and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile